AIAI - AIAI Holdings Corporation Class A Common Stock

AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence

Platform Connects Customer Traffic With Point-of-Sale, Labor, Marketing and Weather Data to Identify Missed Demand, Explain Performance Shifts and Recommend Next Actions Across One Location or Hundreds DALLAS, TX / ACCESS Newswire / August 11, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, Constellation Network has commercially launched Dôr Retail Intelligence, a platform for physical commerce powered by the industry's first thermal-sensing, battery-operated people counter that is currently deployed in over 2,000 retail stores to help businesses better understand customer demand, improve operational performance and guide smarter decisions. Built upon more than a decade of customer traffic analytics, Dôr Retail Intelligence combines traffic data with point of sale, e-commerce, labor, weather and other operational information to identify missed demand, explain business performance and recommend actionable next steps.

Aug 11, 2026 04:30 AM • accessnewswire.com

AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare

New service combines advanced diagnostics, predictive health intelligence and world-class physician expertise to enable earlier detection and expert resolution DALLAS, TX / ACCESS Newswire / August 6, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide, has launched its Longevity Intelligence Service, the latest advancement in its expanding precision healthcare platform. MediGuide's Longevity Intelligence is a service designed to help individuals better understand their biological health, identify potential health risks earlier and receive personalized clinical guidance through an integrated preventive healthcare solution that combines advanced diagnostics, predictive health intelligence, physician expertise and coordinated care.

Aug 06, 2026 04:30 AM • accessnewswire.com

AIAI Deploys Bid Accelerator, Showcasing Its Transformational AI Integration Strategy

Purpose-built AI application deployed at C.C. Carlton Industries, demonstrating AIAI's Transformational AI strategy from framework to operational execution DALLAS, TX / ACCESS Newswire / July 22, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced the deployment of Bid Accelerator a custom built application developed under the Company's Transformational AI (TAI) Integration Playbook, which was introduced in June to provide a disciplined framework for identifying, designing and implementing AI-enabled value creation opportunities across its portfolio companies.

Jul 22, 2026 04:30 AM • accessnewswire.com

AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation

Leveraging Advanced Diagnostics and Screenings to Provide Personalized Proactive Care DALLAS, TX / ACCESS Newswire / July 14, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide, has launched a state of the art (SOTA) precision healthcare solution that combines advanced medical intelligence, expert clinical review, and AI-enabled diagnostic support to enable more personalized, data-driven medical decision-making. The launch represents another milestone in MediGuide's innovation roadmap and reflects AIAI Holdings' strategy of supporting portfolio companies that responsibly integrate advanced technologies into scalable, real-world business applications.

Jul 14, 2026 06:40 AM • accessnewswire.com

NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner

New agreement is a significant commercial milestone and the Company's first with its contract research organization partner Agreement expands NetraMark's portfolio of AI-driven projects in central nervous system (CNS) disorders TORONTO, July 09, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing advanced artificial intelligence solutions for clinical trial optimization and precision medicine, today announced that it signed a new contract to analyze a phase 2 neurodegeneration dataset through its established contract research organization (CRO) partnership. “This contract is an important commercial milestone for NetraMark because it represents our first contract flowing through a CRO, rather than directly with a biopharmaceutical company,” said George Achilleos, Chief Executive Officer of NetraMark.

Jul 09, 2026 03:00 AM • globenewswire.com

AIAI Holdings' Constellation Network Launches Gate AI: Real-Time Security for AI Applications

AI security gateway delivering prompt injection protection, token cost reduction, and verified auditability through Constellation Digital Evidence DALLAS, TX / ACCESS Newswire / July 8, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, Constellation Network has publicly launched Gate AI. Gate AI is a security layer that sits between an AI application and the model, protecting requests in real time.

Jul 08, 2026 04:30 AM • accessnewswire.com

AIAI Holdings' MediGuide Launches Digital Platform

Digital Transformation Initiative Establishes Operational Foundation for Innovation in Diagnostics, Prevention and Precision Medicine DALLAS, TX / ACCESS Newswire / July 1, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide International, has launched a new enterprise digital platform. MediGuide's digital platform is an API-first, interoperable layer that connects insurers, payors, and digital health partners to MediGuide's clinical services, Medical Second Opinion, virtual urgent/primary/behavioral/specialty care, and chronic condition programs, through a single, configurable integration.

Jul 01, 2026 04:30 AM • accessnewswire.com

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that it has signed a new agreement with a biopharmaceutical company developing a late-stage central nervous system therapy.

Jun 29, 2026 03:00 AM • globenewswire.com

AIAI Holdings Unveils AI Integration Playbook for Portfolio Companies

Strategic framework meets businesses where they are today, identifying Transformational AI enabled value creation opportunities DALLAS, TX / ACCESS Newswire / June 23, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announces its strategic and comprehensive post-acquisition AI integration framework, pursuant to which it will identify, design, and implement AI-enabled value creation opportunities across the Company's portfolio businesses. This disciplined, repeatable playbook is expected to move portfolio companies from initial operational assessment to active Transformational AI implementation, fundamentally redefining their financial potential.

Jun 23, 2026 04:30 AM • accessnewswire.com

Rochon Family Executes Strategic Purchase of AIAI Holdings Shares

DALLAS, TX / ACCESS Newswire / June 18, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai²" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that John P. Rochon, Chairman of Ai² and entities controlled by the family of Mr.

Jun 18, 2026 04:30 AM • accessnewswire.com

NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.

Jun 09, 2026 03:00 AM • globenewswire.com

AIAI Holdings and Constellation Network Launch Arca Wallet, a Wallet to Self-Manage Digital Dollars

New Mobile Wallet Combines Digital Dollar Management, Streamlined Identity Verification and an Integrated App Marketplace Designed to Expand Access to Global Payments DALLAS, TX / ACCESS Newswire / June 2, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, along with its subsidiary portfolio company Constellation Network, a blockchain and data infrastructure company, today announced the public launch of Arca Wallet, a self-custodial mobile dollar wallet that enables anyone, anywhere, to hold, send, and manage digital dollars directly from their smartphone. Arca Wallet is available for download on the App Store and Google Play.

Jun 02, 2026 04:30 AM • accessnewswire.com

AIAI Holdings' Constellation Network Unveils Gate AI Security Gateway and Performance Benchmarks Ahead of June Launch

Technical report identifies Gate AI as one of the top performing AI security gateways across 16 public prompt injection evaluations, ranking first on half of the evaluated datasets. DALLAS, TX / ACCESS Newswire / May 28, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that one of its portfolio companies, Constellation Network, its blockchain and data infrastructure company, will launch its AI security gateway product, Constellation Gate AI, in June 2026.

May 28, 2026 04:30 AM • accessnewswire.com

NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting

Company to participate in plenary panel on artificial intelligence in psychiatry and present two scientific posters highlighting explainable AI applications in precision psychiatry Company to participate in plenary panel on artificial intelligence in psychiatry and present two scientific posters highlighting explainable AI applications in precision psychiatry

May 20, 2026 03:00 AM • globenewswire.com

AIAI Holdings Adds Blockchain Data Infrastructure Capabilities With the Acquisition of Constellation Network

In a Landmark Moment for Web3, a Layer 1 Blockchain Infrastructure Company Enters the Public Markets Through a Diversified Holding Company DALLAS, TX / ACCESS Newswire / May 19, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today is highlighting Constellation Network, one of its portfolio of companies. Constellation Network is a technology company that includes a Layer 1 blockchain used for powering enterprise data solutions and AI.

May 19, 2026 04:30 AM • accessnewswire.com

AIAI Holdings Corporation Expresses Appreciation to Revere Securities for Financial Advisory Support on Successful NASDAQ Direct Listing

DALLAS, TX / ACCESS Newswire / May 15, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today would like to thank Revere Securities LLC for their financial advisory support and capital markets coordination in connection with the Company's successful direct listing on the NASDAQ Global Market. AIAI Holdings Corporation began trading on the NASDAQ Global Market under the ticker symbol "AIAI" on May 14, 2026.

May 15, 2026 04:30 AM • accessnewswire.com

NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today provided a business update highlighting key accomplishments during its second fiscal quarter ended March 31, 2026, as well as subsequent developments.

May 14, 2026 01:00 PM • globenewswire.com

AIAI Holdings Corporation Begins Trading on NASDAQ Under Ticker 'AIAI'

Amplifying Intelligence and Redefining Success by Launching a New Era of Real-World AI Implementation DALLAS, TX / ACCESS Newswire / May 14, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that its Class A common shares have begun trading on the NASDAQ Global Market under the ticker symbol "AIAI." "It's an exciting day for us to debut on NASDAQ," said CEO and co-founder Todd Furniss.

May 14, 2026 08:00 AM • accessnewswire.com

NetraMark Announces Change To Board Of Directors

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy has resigned from the Company's Board of Directors, effective May 7, 2026, for personal reasons. The Board and management of NetraMark thank Mr.

May 07, 2026 12:30 PM • globenewswire.com

NetraMark Holdings Inc. (AIAI) Opens the Market

Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - George Achilleos, Chief Executive Officer, NetraMark Holdings Inc. ("NetraMark", or the "Company") (TSX: AIAI) and their executive team, joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange ("TSX"), to open the market to celebrate the Company's new listing on TSX. Cannot view this video?

May 05, 2026 06:40 AM • newsfilecorp.com